Challenges and Opportunities in the Development of Organometallic Anticancer Drugs

Christian G. Hartinger, Nils Metzler‐Nolte, Paul J. Dyson

Organometallics · 2012 · 553 citations · 111 references

DOIFull text

Open access

Concepts

Abstract

This review provides an introduction into the fascinating area of organometallic anticancer compounds. Although the subject dates back many years, it has witnessed considerable growth only in the past decade. A brief overview of the subject together with recent pertinent examples is provided. The properties of organometallic compounds that lend themselves to medical applications, the main current approaches used, and possible avenues for future research are identified.

References

111